Jiangsu Hengrui Pharmaceuticals (01276) plans to repurchase 1-2 billion RMB worth of A-shares.

Jiangsu Hengrui Pharmaceuticals (01276) has announced that, based on confidence in the company's future development prospects and fundamental strengths, and in order to safeguard the interests of the company and its vast number of investors, the company will improve its long-term incentive mechanism for employees. In order to fully motivate employees, the company plans to repurchase its A shares using its own funds. The total amount of funds to be used for the repurchase will not be less than 1 billion yuan and not exceed 2 billion yuan. The repurchase price will not exceed 90.85 yuan per share. The repurchased shares will be used for the A share employee stock ownership plan.